Are women still under-represented in clinical trials?
A breakdown of a recent Nature Communications study examining women’s representation in pivotal clinical trials for FDA-approved drugs.
Source: Zaaijer, S., Groen, S.C. Sex representation in trials relative to indication-specific disease burden in FDA-approved drugs (2015–2023). Nat Commun 17, 6962 (2026). https://doi.org/10.1038/s41467-026-74469-z
